  The present study was conducted to evaluate the supplementation of three autochthonous Bacillus<pathogen> strains ( B.<pathogen> subtilis<pathogen> , B. amyloliquefaciens and B.<pathogen> cereus<pathogen>) and a commercial B. amyloliquefaciensin doses of 1 Ã— 10